Papillary and follicular thyroid cancer, together referred to as differentiated thyroid cancer
(DTC), is usually curable when discovered at an early stage. Its management, however, is …

This is a comprehensive presentation of the risks and benefits of radioiodine-131 in the
treatment of metastatic well differentiated thyroid cancer. In addition, methods to optimize the …

A randomized evaluation of the effectiveness and toxicity of the combination of doxorubicin
and cisplatin and of doxorubicin alone in patients with advanced thyroid carcinoma was …

The Clinical Practice Guidelines for the Management of Thyroid Carcinoma represent the
third set of thyroid disease management guidelines produced by the American Association …

Use of radioactive iodine is an essential adjuvant treatment strategy after thyroidectomy in
patients with differentiated thyroid carcinoma. Although generally safe, radioiodine therapy …

To describe the clinical characteristics and define the indicators that best predict survival in
patients with bone metastases from thyroid carcinomas. We collected data from medical …

MATERIALS AND METHODS Patients. One or more tumors that were histologically typical of
pheochnomocytoma had been removed from each patient; de-differentiation of histology …

Radionuclide therapy (RNT) based on the concept of delivering cytotoxic levels of radiation
to disease sites is one of the rapidly growing fields of nuclear medicine. Unlike conventional …

Benua, Leeper, and others (BEL) have advocated the estimation of radiation exposure to the
blood to select a more rational maximum safe dose of radioiodine (dosimetry) to treat …

Radioactive iodine (RAI) in the form of 131 I has been used to treat thyroid cancer since
1946. RAI is used after thyroidectomy to ablate the residual normal thyroid remnant, as …